Micro-MRI improves the accuracy of clinical diagnosis in cerebral small vessel disease

Hidehiro Ishikawa1, Atsushi Niwa1, Shinya Kato2

  • 1Department of Neurology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

Insights

Ex vivo MRI enhances diagnosis of small cerebral lesions in small vessel disease. This study reveals non-amyloid angiopathy causes of microbleeds, improving clinical understanding.

Area of Science:

  • Neurology
  • Radiology
  • Pathology

Background:

  • Small vessel disease diagnosis is challenging using in vivo imaging.
  • Postmortem examination offers limited clinical insight into in vivo lesions.
  • Cerebral small vessel disease is linked to aging, dementia, and stroke.

Purpose of the Study:

  • To compare in vivo MRI findings with ex vivo MRI and pathological examination of small cerebral lesions.
  • To investigate the pathological basis of lesions detected by in vivo MRI in patients with small vessel disease.

Main Methods:

  • A radiological-pathological comparative study was performed.
  • Ex vivo MRI was used to examine small cerebral lesions in four patients.
  • Lesions detected on in vivo MRI were analyzed pathologically.

Main Results:

  • Ischemic lesions showed sterile inflammation and neuroprotective reactions.
  • Cortical microinfarcts were associated with inflammation in a cerebral amyloid angiopathy case.
  • Ex vivo MRI revealed heterogeneous cerebral microbleeds, including venous angiomas and embolic microbleeds.
  • This method enabled the first neuropathologically confirmed detection of embolic cerebral microbleeds.

Conclusions:

  • Ex vivo micro-MRI improves the clinical diagnosis of small vessel diseases.
  • Lobar cerebral microbleeds detected in vivo can stem from non-cerebral amyloid angiopathy causes like microembolism and venous angioma.
  • Venous angiomas and embolic microbleeds may mimic cerebral amyloid angiopathy markers on in vivo MRI.